https://www.zonebourse.com/cours/action/REMEGEN-CO-LTD-119080101/actualite/La-National-Medical-Products-Administration-approuve-la-demande-de-DNR-pour-la-Disitamab-Vedotin-de-42656388/?utm_source=telegram&utm_medium=social&utm_campaign=share